The ABCG5 ABCG8 sterol transporter and phytosterols: implications for cardiometabolic disease
- PMID: 19306529
- PMCID: PMC4097028
- DOI: 10.1097/med.0b013e3283292312
The ABCG5 ABCG8 sterol transporter and phytosterols: implications for cardiometabolic disease
Abstract
Purpose of review: This review summarizes recent developments in the activity, regulation, and physiology of the ABCG5 ABCG8 (G5G8) transporter and the use of its xenobiotic substrates, phytosterols, as cholesterol lowering agents in the treatment of cardiovascular disease. Recent progress has significant implications for the role of G5G8 and its substrates in complications associated with features of the metabolic syndrome.
Recent findings: Recent reports expand the clinical presentation of sitosterolemia to include platelet and adrenal dysfunction. The G5G8 sterol transporter is critical to hepatobiliary excretion of cholesterol under nonpathological conditions and has been linked to the cholesterol gallstone susceptibility. Finally, the cardiovascular benefits of cholesterol lowering through the use of phytosterol supplements were offset by vascular dysfunction, suggesting that alternative strategies to reduced cholesterol absorption offer greater benefit.
Summary: Insulin resistance elevates G5G8 and increases susceptibility to cholesterol gallstones. However, this transporter is critical for the exclusion of phytosterols from the absorptive pathways in the intestine. Challenging the limits of this protective mechanism through phytosterol supplementation diminishes the cardioprotective benefits of cholesterol lowering in mouse models of cardiovascular disease.
Figures


Similar articles
-
Association of ABCG5 and ABCG8 Transporters with Sitosterolemia.Adv Exp Med Biol. 2024;1440:31-42. doi: 10.1007/978-3-031-43883-7_2. Adv Exp Med Biol. 2024. PMID: 38036873 Review.
-
Relative roles of ABCG5/ABCG8 in liver and intestine.J Lipid Res. 2015 Feb;56(2):319-30. doi: 10.1194/jlr.M054544. Epub 2014 Nov 6. J Lipid Res. 2015. PMID: 25378657 Free PMC article.
-
The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation.J Biol Chem. 2012 Aug 17;287(34):28564-75. doi: 10.1074/jbc.M112.360081. Epub 2012 Jun 19. J Biol Chem. 2012. PMID: 22715101 Free PMC article.
-
Selective sterol accumulation in ABCG5/ABCG8-deficient mice.J Lipid Res. 2004 Feb;45(2):301-7. doi: 10.1194/jlr.M300377-JLR200. Epub 2003 Dec 1. J Lipid Res. 2004. PMID: 14657202
-
Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterols.Pflugers Arch. 2007 Feb;453(5):745-52. doi: 10.1007/s00424-005-0040-7. Epub 2006 Jan 27. Pflugers Arch. 2007. PMID: 16440216 Free PMC article. Review.
Cited by
-
ABCG8‑mediated sterol efflux increases cancer cell progression via the LRP6/Wnt/β‑catenin signaling pathway in radiotherapy‑resistant MDA‑MB‑231 triple‑negative breast cancer cells.Int J Mol Med. 2025 May;55(5):80. doi: 10.3892/ijmm.2025.5521. Epub 2025 Mar 21. Int J Mol Med. 2025. PMID: 40116083 Free PMC article.
-
Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.Adv Exp Med Biol. 2020;1276:105-136. doi: 10.1007/978-981-15-6082-8_8. Adv Exp Med Biol. 2020. PMID: 32705597 Free PMC article. Review.
-
Genes Potentially Associated with Familial Hypercholesterolemia.Biomolecules. 2019 Nov 29;9(12):807. doi: 10.3390/biom9120807. Biomolecules. 2019. PMID: 31795497 Free PMC article. Review.
-
Fatty acids modulate the expression levels of key proteins for cholesterol absorption in Caco-2 monolayer.Lipids Health Dis. 2018 Feb 20;17(1):32. doi: 10.1186/s12944-018-0675-y. Lipids Health Dis. 2018. PMID: 29463265 Free PMC article.
-
The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.J Lipid Res. 2015 Apr;56(4):810-20. doi: 10.1194/jlr.M053454. Epub 2015 Jan 29. J Lipid Res. 2015. PMID: 25635125 Free PMC article.
References
-
- Kidambi S, Patel SB. Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis. J Clin Pathol. 2008;61:588–594. - PubMed
-
- Kidambi S, Patel SB. Cholesterol and noncholesterol sterol transporters: ABCG5, ABCG8 and NPC1L1– a review. Xenobiotica. 2008;38:1119–1139. - PubMed
-
- Kruit JK, Drayer AL, Bloks VW, et al. Plant sterols cause macrothrombocytopenia in a mouse model of sitosterolemia. J Biol Chem. 2008;283:6281–6287. This study provides a mechanism for platelet dysfunction sitosterolemia. - PubMed
-
- Mushtaq T, Wales JK, Wright NP. Adrenal insufficiency in phytosterolaemia. Eur J Endocrinol. 2007;157(Suppl 1):S61–S65. - PubMed
-
- Tang W, Ma Y, Jia L, et al. Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8. J Lipid Res. 2009;50:293–300. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials